These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 10088236

  • 1. [Medical-economic evaluation of bronchial cancer].
    Vergnenegre A.
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S38-9. PubMed ID: 10088236
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L, Bowman L, Chang S, Long SR, Obasaju C, Crown WH.
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [Abstract] [Full Text] [Related]

  • 5. [Decision analysis: application of a diagnostic and therapeutic strategy in cases of bronchial carcinoma].
    Junod AF, Housset B.
    Rev Mal Respir; 1988 Nov; 5(5):497-504. PubMed ID: 3055096
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Economic analysis of cancer treatment costs: another tool for oncology managers.
    Chirikos TN, Ruckdeschel JC, Krischer JP.
    J Oncol Manag; 2001 Nov; 10(3):11-7. PubMed ID: 11548179
    [Abstract] [Full Text] [Related]

  • 9. [Approach to the patient with bronchial cancer by the practicing physician].
    Sculier JP, Klastersky J.
    Rev Med Brux; 1986 Oct; 7(8):473-9. PubMed ID: 3541102
    [No Abstract] [Full Text] [Related]

  • 10. [The significance of tumor-associated antigens in the diagnosis and therapeutic control of bronchial cancer].
    Gropp C, Luster W, Havemann K.
    Prax Klin Pneumol; 1982 Dec; 36(12):491-9. PubMed ID: 7163127
    [No Abstract] [Full Text] [Related]

  • 11. [Primary bronchopulmonary cancer. Epidemiology, etiology, diagnosis, evolution and prognosis, principles of medical and surgical treatment].
    Dautzenberg B.
    Rev Prat; 1989 Mar 16; 39(9):805-12. PubMed ID: 2660244
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Evaluation criteria for bronchial carcinoma. How to assess quality of life in lung cancer?].
    Souquet PJ, Gérinière L.
    Rev Mal Respir; 2006 Nov 16; 23(5 Pt 3):16S112-16S117. PubMed ID: 17268347
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Bronchial carcinoma (lung cancer)].
    Häussinger K, Huber RM.
    Pneumologie; 1996 Sep 16; 50 Suppl 2():599-603. PubMed ID: 9157424
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Screening studies of lung cancer: implications for monitoring of pulmonary nodules].
    Girard N, Cordier JF.
    Rev Prat; 2012 Jun 16; 62(6):821-2. PubMed ID: 22838285
    [No Abstract] [Full Text] [Related]

  • 20. [Bronchial carcinoma: how far should the diagnosis go?].
    Macha HN.
    Pneumologie; 1991 Jun 16; 45(6):508-10. PubMed ID: 1924226
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.